Joaquı́n MateoFollowVall d'Hebron Hospital Universitari1 paperORCID 0000-0001-5336-2548 ↗OpenAlex ↗PapersThe Lancet OncologyReview·26 SepBalancing benefits, costs, and harms: policy implications of expanding cancer susceptibility testing from genetics clinics to the general population
The Lancet OncologyReview·26 SepBalancing benefits, costs, and harms: policy implications of expanding cancer susceptibility testing from genetics clinics to the general population